CompletedPhase 2NCT04325035

The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock

Studying Cardiogenic shock

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Windtree Therapeutics
Principal Investigator
Marco Metra, MD
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Italy
Intervention
Istaroxime(drug)
Enrollment
90 enrolled
Eligibility
18-85 years · All sexes
Timeline
20202024

Study locations (13)

Collaborators

Momentum Research, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04325035 on ClinicalTrials.gov

Other trials for Cardiogenic shock

Additional recruiting or active studies for the same condition.

See all trials for Cardiogenic shock

← Back to all trials